Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: Role of insulin

Peptides

Volumn 28, Issue 5, 2007, Pages 1040-1049

  Rastelli, Viviani Milan Ferreira ^a   Oliveira, Maria Aparecida ^a   dos Santos, Rosangela ^a   de Cássia Tostes Passaglia, Rita ^a   Nigro, Dorothy ^a   de Carvalho, Maria Helena Catelli ^a   Fortes, Zuleica Bruno ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin (1 7) insulin; Bradykinn; Type 2 diabets

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN[1-7]; BRADYKININ; INDOMETACIN; INSULIN; ISOPHANE INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; OUABAIN; STREPTOZOCIN; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FOOD INTAKE; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; MICROSCOPY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ANGIOTENSIN I; ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; BRADYKININ; DIABETES MELLITUS, TYPE 2; DRUG INTERACTIONS; GENE EXPRESSION; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; INSULIN; MALE; NG-NITROARGININE METHYL ESTER; OUABAIN; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, BRADYKININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOZOCIN; TETRAETHYLAMMONIUM; VASODILATION;

RATTUS; STROPHANTHUS GRATUS;

EID: 34247638628     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.02.006     Document Type: Article

References (49)

1. Almeida A.P., Fábregas B.C., Madureira M.M., Santos R.J.S., Campagnole-Santos M.J., and Santos R.A.S. Angiotensin-(1-7) potentiates the coronary vasodilatory effect of bradykinin in the isolated rat heart. Braz J Mol Biol Med 33 (2000) 709-713
2. Arganaraz G.A., Silva Jr. J.A., Perosa S.R., Pessoa L.G., Carvalho F.F., Bascands J.L., et al. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Brain Res 1006 1 (2004) 114-125
3. Arulmozhi D.K., Veeranjaneyulu A., and Bodhankar S.L. Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus: a glance. Indian J Pharmacol 36 (2004) 217-221
4. Baez S. Simultaneous measurements of radii and wall thickness of microvessels in the anesthetized rat. Circ Res 25 (1969) 315-329
5. Bonora E., Moghetti P., Zancanaro C., Cigolini M., Querena M., Cacciatoni V., et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68 (1989) 374-378
6. Brodsky S.V., Morrishow A.M., Dharia N., Gross S.S., and Goligorsky M.S. Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 280 (2001) F480-F486
7. Brosnihan K.B., Li P., and Ferrario C.M. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27 (1996) 523-528
8. Campbell D.J. The renin-angiotensin and the kallikrein-kinin systems. Int J Biochem Cell Biol. 35 6 (2003) 784-791
9. Damas J., Garbacki N., and Lefebvre P.J. The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity. Diabetes Metab Res Rev 20 4 (2004) 288-297
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 Jan; 26 Suppl 1: S5-20.
11. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Phys Rev 98 (1998) 53-97
12. Fernandes L., Fortes Z.B., Nigro D., Tostes R.C.A., Santos R.A.S., and Carvalho M.H.C. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension 37 2 Part 2 (2001) 703-709
13. Fortes Z.B., Garcia-Leme J., and Scivoletto R. Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine. Br J Pharmacol 78 (1983) 39-48
14. Fortes Z.B., Garcia-Leme J., and Scivoletto R. Vascular reactivity in diabetes mellitus: possible role of insulin on the endothelial cell. Br J Pharmacol 83 (1984) 625-643
15. Fortes Z.B., Garcia-Leme J., and Scivoletto R. Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br J Pharmacol 79 (1983) 771-781
16. Fortes Z.B., Scivoletto R., and Garcia-Leme J. Functional changes in the microcirculation of alloxan-induced diabetic rats. Gen Pharmacol 20 (1989) 615-620
17. Garcia-Leme J., Hamamura L., Migliorin R.H., and Leite M.P. Influence of diabetes upon the inflammatory response of the rat. A pharmacological analysis. Eur J Pharmac 23 (1973) 74-81
18. Garcia-Leme J. Hormones and inflammation (1989), CRC, Boca Raton, FL
19. Garcia-Leme J. Regulatory mechanisms inflammation. New aspects of autopharmacology. Gen Pharmacol 12 (1981) 15-24
20. Garland C.J., Plane F., Kemp B.K., and Cocks T.M. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 16 5 (1995) 177
21. Grill V., Westberg M., and Ostenson C.G. B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia. J Clin Invest 80 3 (1987) 664-669
22. + pump activity by insulin and nitric oxide in rabbit aorta. Am J Physiol 270 (1996) 1287-1293
23. Hemmings S.J., and Spafford D. Neonatal STZ model of type II diabetes mellitus in the Fischer 344 rat: characteristics and assessment of the status of the hepatic adrenergic receptors. Int J Biochem Cell Biol 32 8 (2000) 905-919
24. Iwase M., Kikuchi M., Nunoi K., Wakisaka M., Maki Y., Sadoshima S., et al. A new model of type 2 (non-insulin-dependent) diabetes mellitus in spontaneously hypertensive rats: diabetes induced by neontal streptozotocin treatment. Diabetologia 29 11 (1986) 808-811
25. Kiff R.J., Gardiner S.M., Compton A.M., and Bennett T. Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103 (1991) 1357-1362
26. Kobayashi T., and Kamata K. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atherosclerosis 155 (2001) 313-321
27. Koo J.R., and Vaziri N.D. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 63 (2003) 195-201
28. Kudoh A., Dietize G.J., and Rabito S.F. Insulin enhances the bradykinin response in L8 rat skeletal myoblasts. Diabetes 49 (2000) 190-194
29. Leung P.S. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes. Diabet Med 24 2 (2007) 110-116
30. Li P., Chappell M.C., Ferrario C.M., and Brosnihan K.B. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE releasing nitric oxide. Hypertension 29 (1997) 394-400
31. Lima C.V., Paula R.D., Resende F.L., Khosla M.C., and Santos R.A.S. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension 30 2 (1997) 542-548
32. Liu Z. The renin-angiotensin system and insulin resistance. Curr Diab Rep 7 1 (2007) 34-42
33. Oliveira M.A., Carvalho M.H., Nigro D., Passaglia Rde C., and Fortes Z.B. Elevated glucose blocks angiotensin-(1-7) and bradykinin interaction: the role of cyclooxygenase products. Peptides 24 3 (2003) 449-454
34. Oliveira M.A., Carvalho M.H.C., Nigro D., Tostes R.C.A., and Fortes Z.B. Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: in vivo study. Peptides 23 (2002) 1449-1455
35. Oliveira M.A., Fortes Z.B., Santos R.A.S., Khosla M.C., and Carvalho M.H.C. Synergistic effect of angiotensin-(1-7) on bradykinin induced vasodilation on rat mesenteric microvessels in vivo. Peptides 20 (1999) 1195-1201
36. Paula R.D., Lima C.V., Khosla M.C., and Santos R.A.S. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 26 (1995) 1154-1159
37. Pereira M.A.A., Sannomiya P., and Leme J.G. Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes 36 (1987) 1307-1314
38. Rastelli V.M.F., Akamine E.H., Oliveira M.A., Nigro D., Tostes R.C.A., Carvalho M.H.C., et al. Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. Inflamm Res 54 4 (2005) 173-179
39. Santos R.A.S., Campagnole-Santos M.J., and Andrade S.P. Angiotensin-(1-7): an update. Regul Pept 91 (2000) 45-62
40. Santos R.A.S., Passaglio T.K., Pesquero J.B., Bader M., and Simões e Silva A.C. Interactions between angiotensin-(1-7), kinins and angiotensin II in kidney and blood vessels. Hypertension. 38 Part 2 (2001) 660-664
41. Sartoretto J.L., Melo G.A.N., Carvalho M.H.C., Nigro D., Tostes R.C.A., Scavone C., et al. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression. Life Sci 77 21 (2005) 2676-2689
42. Scheen A.J. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 30 6 (2004) 498-505
43. Scherrer U., Randin D., Vollenweider P., Vollenweider L., and Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94 (1994) 2511-2515
44. Spanswick D., Smith M.A., Mirshamsi S., Routh V.H., and Ashford M.L.J. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 3 (2000) 757-758
45. Steinberg H.O., Brechtel G., Jonhson A., and Baron A.D. Insulin modulates endothelium derived relaxing factor nitric oxide dependent vasodilation in skeletal muscle. Hypertension 22 3 (1993) 436
46. Tikellis C., Cooper M.E., and Thomas M.C. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes. Int J Biochem Cell Biol 38 5/6 (2006) 737-751
47. Ver A., Szanto I., Banyasz T., Csermely P., Vegh E., and Somogyi J. Changes in the expression of Na+/K+-ATPase isoenzymes in the left ventricle of diabetic rat hearts: effect of insulin treatment. Diabetologia 40 11 (1997) 1255-1262
48. Welsh N., and Hellerstrom C. In vitro restoration of insulin production in islets from adult rats treated neonatally with streptozotocin. Endocrinology 126 4 (1990) 1842-1848
49. Zweifach B.W. Indirect methods for regional blood flow I. Microscopic observation of circulation in rat mesoappendix and dog omentum. Use in study of vasotropic substances. Meth Med Res 1 (1948) 131-138